Search

Search Constraints

You searched for: Author/Creator Weitzman, Ron

Search Results

1. A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma. (September 2017)

2. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy. Issue 2 (14th August 2017)

3. Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy. Issue 2 (3rd October 2017)

4. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Issue 10 (5th April 2018)